Delivery of Platelet-Derived Growth Factor as a Chemotactic Factor for Mesenchymal Stem Cells by Bone-Mimetic Electrospun Scaffolds
暂无分享,去创建一个
[1] Matthew C. Phipps,et al. Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. , 2012, Biomaterials.
[2] Kam W Leong,et al. Controlled release from fibers of polyelectrolyte complexes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[3] S. Lee,et al. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[4] S. Lynch,et al. Augment Bone Graft Products Compare Favorably With Autologous Bone Graft in an Ovine Model of Lumbar Interbody Spine Fusion , 2012, Spine.
[5] N. Gallay,et al. The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities , 2007, Stem cells.
[6] R. Gay,et al. Angiogenic and angiostatic factors in the molecular control of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[7] Reva M. Street,et al. Preclinical Toxicology Studies of Recombinant Human Platelet-Derived Growth Factor-BB Either Alone or in Combination with Beta-Tricalcium Phosphate and Type I Collagen , 2010, Journal of tissue engineering.
[8] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[9] Johanna Andrae,et al. Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.
[10] Peter X. Ma,et al. Nanofibrous Scaffolds Incorporating PDGF-BB Microspheres Induce Chemokine Expression and Tissue Neogenesis In Vivo , 2008, PloS one.
[11] A. Mantalaris,et al. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing , 2009, Expert opinion on investigational drugs.
[12] C. Heldin,et al. Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.
[13] L. Snel,et al. Safety of recombinant human platelet-derived growth factor-BB in Augment® Bone Graft , 2012, Journal of tissue engineering.
[14] Jeffrey M Karp,et al. Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.
[15] A. Rot,et al. Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human , 2008, PloS one.
[16] R. Coutts,et al. Growth factors as therapeutic agents. , 1997, Instructional course lectures.
[17] R. Ross,et al. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. , 1990, Biochemistry.
[18] Devotha Nyambo,et al. Applications: A Review , 2014 .
[19] Robert J. Kane,et al. Biomimetic Nanofibrous Scaffolds for Bone Tissue Engineering Applications , 2013 .
[20] L. Ghasemi‐Mobarakeh,et al. Electrospun composite nanofibers for tissue regeneration. , 2011, Journal of nanoscience and nanotechnology.
[21] Y. Kato,et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. , 2007, Stem cells and development.
[22] R. Kitazawa,et al. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. , 1999, Histochemistry and cell biology.
[23] V. Denaro,et al. Electrospun scaffolds for bone tissue engineering , 2011, Musculoskeletal surgery.
[24] J. Homsi,et al. Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors. , 2007, Cancer control : journal of the Moffitt Cancer Center.
[25] R. Ross,et al. The B chain of PDGF alone is sufficient for mitogenesis. , 1985, The EMBO journal.
[26] David J. Mooney,et al. Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation , 2007, Pharmaceutical Research.
[27] Cameron J Wilson,et al. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. , 2005, Tissue engineering.
[28] Hae-Won Kim,et al. Electrospun materials as potential platforms for bone tissue engineering. , 2009, Advanced drug delivery reviews.
[29] C. Bünger,et al. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. , 1996, Bone.
[30] Matthew C. Phipps,et al. Mesenchymal Stem Cell Responses to Bone-Mimetic Electrospun Matrices Composed of Polycaprolactone, Collagen I and Nanoparticulate Hydroxyapatite , 2011, PloS one.
[31] A. Mikos,et al. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. , 2006, Tissue engineering.
[32] R. Ross,et al. Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. , 1984, Blood.
[33] F. Frommlet,et al. Platelets are mitogenic for periosteum‐derived cells , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[34] S. Lynch,et al. Recombinant human platelet-derived growth factor: biology and clinical applications. , 2008, The Journal of bone and joint surgery. American volume.
[35] Peter X Ma,et al. Biomimetic nanofibrous scaffolds for bone tissue engineering. , 2011, Biomaterials.
[36] F. Javed,et al. Significance of the platelet-derived growth factor in periodontal tissue regeneration. , 2011, Archives of oral biology.
[37] L. Applegate,et al. Regulation of proliferation and differentiation of human fetal bone cells. , 2011, European cells & materials.
[38] William V Giannobile,et al. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[39] C. Ladd,et al. Determination and expression of platelet-derived growth factor-AA in bone cell cultures. , 1992, Endocrinology.
[40] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[41] Hang Lin,et al. The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. , 2006, Biomaterials.
[42] E. Canalis,et al. Role of platelet derived growth factor in bone cell function. , 1992, Growth regulation.
[43] C. Heldin,et al. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[44] Zhifeng Xiao,et al. Direct chemical cross-linking of platelet-derived growth factor-BB to the demineralized bone matrix improves cellularization and vascularization. , 2009, Biomacromolecules.
[45] D. Prockop,et al. Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.
[46] S. Ahmed,et al. Biology and clinical applications , 2004 .
[47] Zhi-Ren Liu,et al. P68 RNA Helicase Mediates PDGF-Induced Epithelial Mesenchymal Transition by Displacing Axin from β-Catenin , 2006, Cell.